# Bedside Genetic or Pharmacodynamic Testing to Prevent Periprocedural Myonecrosis During PCI (ONSIDE TEST)

> **NCT01930773** · PHASE3 · UNKNOWN · sponsor: **Medical University of Warsaw** · enrollment: 150 (estimated)

## Conditions studied

- Stable Angina

## Interventions

- **DEVICE:** Genotyping
- **DEVICE:** Phenotyping

## Key facts

- **NCT ID:** NCT01930773
- **Lead sponsor:** Medical University of Warsaw
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-03
- **Primary completion:** 2019-03
- **Final completion:** 2019-09
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2018-12-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01930773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01930773, "Bedside Genetic or Pharmacodynamic Testing to Prevent Periprocedural Myonecrosis During PCI (ONSIDE TEST)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01930773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*